Product Information
LOPERAMIDE 2 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0541 per EA under NDC 00093031105. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093031105
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073192On Market Since
5/1/1993
Pharmacological Classes
Price Statistics
The NADAC for LOPERAMIDE 2 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0541 per EA |
|---|---|
| All-time high | $0.3427 (Feb 10, 2016) |
| All-time low | $0.0520 (Feb 18, 2026) |
| 52-week high | $0.1160 |
| 52-week low | $0.0520 |
| Median price | $0.2788 |
| Average price | $0.2396 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOPERAMIDE 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOPERAMIDE 2 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.0541 per EA (NDC 00093031105), effective Jun 24, 2026.
How has the price of LOPERAMIDE 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOPERAMIDE 2 MG CAPSULE has declined 59.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOPERAMIDE 2 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOPERAMIDE 2 MG CAPSULE has ranged from a low of $0.0520 (Feb 18, 2026) to a high of $0.3427 (Feb 10, 2016), with a median of $0.2788 per EA.
Are there cheaper alternatives to LOPERAMIDE 2 MG CAPSULE?
10 NADAC-published products share the same active ingredient, strength, and dosage form as LOPERAMIDE 2 MG CAPSULE, but none are currently priced below it.
Who manufactures LOPERAMIDE 2 MG CAPSULE?
LOPERAMIDE 2 MG CAPSULE (NDC 00093031105) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification